Science Explorer Interactive view Map
Company · Boston · United States

scPharmaceuticals (United States)

scpharmaceuticals.comROR OpenAlex
Research works
78
▼ 45% vs 2013–17
Citations
2.3k
28.8 per fractional work
Top-10% rate
6.6%
record average 16.5%
Open access
45%
world 28%

Not ranked overall: scPharmaceuticals (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 1.87× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 3.62× its world share, 1 worksImmunology and Micro…Neuroscience: 0.98× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 2.91× its world share, 0 worksPharmacology, Toxico…Chemistry: 0.07× its world share, 0 worksChemistryEngineering: 0.01× its world share, 0 worksEngineeringMathematics: 1.12× its world share, 0 worksMathematicsHealth Professions: 0.33× its world share, 0 worksHealth ProfessionsMedicine: 4.15× its world share, 15 worksMedicineEconomics, Econometrics and Finance: 0.60× its world share, 0 worksEconomics, Econometr…Social Sciences: 0.02× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 4.2×. Every wedge is a field page.

Which keywords describe research at scPharmaceuticals (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Cancer, Immunotherapy, Biomarkers, Neuroimaging, Alzheimer's Disease, Imaging, PET/CT and tumor.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Cancer8▲ 6.9×9 topics
  2. Immunotherapy7▲ 13×10 topics
  3. Biomarkers6▲ 12×8 topics
  4. Oxidative Stress6▲ 3.9×10 topics
  5. Neuroimaging6▲ 24×4 topics
  6. Alzheimer's Disease5▲ 24×4 topics
  7. Imaging5▲ 18×2 topics
  8. PET/CT5▲ 84×1 topic
  9. tumor5▲ 84×1 topic
  10. Aging5▲ 11×2 topics
  11. Cancer Immunotherapy5▲ 41×2 topics
  12. Cognitive Decline5▲ 55×1 topic
  13. Dementia5▲ 83×2 topics
  14. Mild Cognitive Impairment5▲ 95×1 topic
  15. Monoclonal Antibodies5▲ 41×3 topics
  16. Glycosylation4▲ 26×3 topics
  17. Inflammation4▲ 2.2×17 topics
  18. Tumor Regression4▲ 62×2 topics
  19. Cardiovascular Disease4▲ 4.6×11 topics
  20. Lymphoma4▲ 35×3 topics
  21. Leukemia4▲ 77×2 topics
  22. Neurodegeneration4▲ 15×6 topics
  23. CAR T Cells4▲ 105×1 topic
  24. Chimeric Antigen Receptor4▲ 105×1 topic
  25. Neuroinflammation4▲ 17×4 topics
  26. Diagnosis4▲ 4.3×6 topics
  27. Therapeutic Antibodies4▲ 35×2 topics
  28. Heart Failure3▲ 9.5×9 topics
  29. Antibody Engineering3▲ 42×1 topic
  30. Fc Receptors3▲ 42×1 topic
  31. Amyloid Hypothesis3▲ 71×1 topic
  32. Tau Pathology3▲ 71×1 topic
  33. Tumor Microenvironment3▲ 9.7×4 topics
  34. Magnetic Resonance Imaging3▲ 8.9×3 topics
  35. Targeted Therapy2▲ 15×4 topics
  36. Clinical Trials2▲ 4.8×8 topics
  37. Precision Medicine2▲ 8.4×3 topics
  38. PET Imaging2▲ 11×4 topics
  39. B-Type Natriuretic Peptide2▲ 48×1 topic
  40. Hospital Readmission2▲ 48×1 topic

Which research topics does scPharmaceuticals (United States) publish most on?

By volume in 2022–2025: CAR-T cell therapy research, Heart Failure Treatment and Management, Urticaria and Related Conditions and Monoclonal and Polyclonal Antibodies Research.

CAR-T cell therapy resea…2CAR-T cell therapy research: 2 fractional worksHeart Failure Treatment …1Heart Failure Treatment and Management: 1 fractional worksUrticaria and Related Co…1Urticaria and Related Conditions: 1 fractional worksMonoclonal and Polyclonal Antibodies Research: 1 fractional worksProtein Degradation and Inhibitors: 1 fractional worksMultiple Myeloma Researc…0Multiple Myeloma Research and Treatments: 0 fractional worksMyeloproliferative Neoplasms: Diagnosis and Treatment: 0 fractional worksDementia and Cognitive Impairment Research: 0 fractional worksAlzheimer's disease research and treatments: 0 fractional worksLiver Disease and Transplantation: 0 fractional works
OncologyCardiology and Cardiovascular MedicineRheumatologyRadiology, Nuclear Medicine and Imaging6 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 CAR-T cell therapy research Oncology 2 works
  2. 2 Heart Failure Treatment and Management Cardiology and Cardiovascular Medicine 1 works
  3. 3 Urticaria and Related Conditions Rheumatology 1 works
  4. 4 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
  5. 5 Protein Degradation and Inhibitors Molecular Biology 1 works
  6. 6 Multiple Myeloma Research and Treatments Hematology 0 works
  7. 7 Myeloproliferative Neoplasms: Diagnosis and Treatment Genetics 0 works
  8. 8 Dementia and Cognitive Impairment Research Psychiatry and Mental health 0 works
  9. 9 Alzheimer's disease research and treatments Physiology 0 works
  10. 10 Liver Disease and Transplantation Hepatology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available44.6%not open55.4%

World: 28% of research is openly available.

with international co-authors29.3%domestic only70.7%

World: 19% is written across borders.

How has scPharmaceuticals (United States)'s research output changed?

Output in 2018–2022 was 45% lower than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Boston

All research institutions in Boston

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.